NEW YORK (GenomeWeb News) – Caprion Proteomics said today that it is working with Applied Biosystems to verify and validate protein biomarker candidates for use in clinical settings.

Caprion said it is using the Life Technologies division's QTRAP technology to develop and deploy multiple reaction monitoring (MRM) assays to validate biomarker candidates. The QTRAP technology is used to integrate quantitative and qualitative analysis through the MIDAS workflow and fast MRM assay development and quantitative results, said Caprion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.